Asthma

Once-daily drug can be used to treat chronic bronchitis and emphysema.

Pharmacists need to remain cognizant of COPD and asthma patient preferences to maintain adherence.

Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients' treatment preferences when chronic disease is present.

Link found between new onset obstructive sleep apnea and habitual sleepiness.

AstraZeneca and Abbott are teaming up to develop companion diagnostic blood tests that will identify patients with severe asthma who would benefit most from biological tralokinumab therapy.

Asthma controller medications are underused in neighborhoods with high rates of asthma-related emergency room use and hospitalization, but pharmacists are in a prime position to correct it.

The FDA today expanded the indication of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma.

Difficulty with several aspects of nebulizer use creates treatment hurdles for patients.

By educating nurses, counseling physicians, and providing feedback on inhalation technique, pharmacists can reduce issues related to salbutamol treatment for asthma and bronchitis, according to research findings.

Most patients who require inhalers for asthma or epinephrine autoinjectors for an allergic disease do not use the devices properly, according to a study.

Just 15% of employed adults with asthma consult with their health care professional on how work conditions might affect their disease, according to a new study.

Maria Marzella Mantione, PharmD, CGP, associate clinical professor in the College of Pharmacy and Health Sciences at St. John's University, talks about some lesser known facts about asthma treatment.

Maria Marzella Mantione, PharmD, CGP, associate clinical professor in the College of Pharmacy and Health Sciences at St. John's University, talks about how community pharmacists can help improve management of asthma in patients.

Efforts are being made to ensure that health care providers deliver the right care at the right time.

Well-trained pharmacists can successfully screen patients for COPD in the community setting.

The FDA today approved Teva's albuterol sulfate inhalation powder (Proair RespiClick).

The FDA's advisory committee supports the approval of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma in only adults.

The FDA is warning health care professionals and patients about OTC asthma products labeled as homeopathic remedies.

From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.

With the wide selection of available inhalers, this article sheds light on factors that can influence COPD treatment success.

A pair of phase 3 studies recently demonstrated that Teva Pharmaceutical Industries' investigational treatment for moderate-to-severe asthma in patients with elevated blood eosinophils reduces asthma exacerbation rates by at least half.

A new start-up is looking to integrate smart sensors into current inhalers to increase adherence.

Student pharmacist-delivered education can have a positive impact on asthma knowledge among children.

Just 15% of employed adults with asthma consult with their health care professional on how work conditions might affect their disease.

By educating nurses, counseling physicians, and providing feedback on inhalation technique, pharmacists can reduce issues related to salbutamol treatment for asthma and bronchitis.

Symptoms include airflow obstruction, bronchial hyperresponsiveness, and airway inflammation.

See a new technique to treat severe asthma.

An examination of the pathophysiology of asthma.

A review of the pathology of asthma and COPD, including the role of the immune system, along with the mechanisms behind the hypercapnia and hypoxemia of COPD, and the blue bloater vs. pink puffer pseudodichotomy.